BWS
GSK icon

Buck Wealth Strategies’s GSK GSK Stock Holding History

Buck Wealth Strategies’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68K Buy
+32
New +$1.69K ﹤0.01% 884

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Buck Wealth Strategies's GSK Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in GSK (GSK) in Q2 2026: 32 shares worth $1.68K. The stake represents ﹤0.01% of the portfolio and ranks #884 among its holdings.

683 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Buck Wealth Strategies held 32 shares of GSK worth $1.68K as of Q2 2026.
  • GSK was a new Buck Wealth Strategies position in Q2 2026.
  • GSK made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #884 holding.
  • 683 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.